ResMed Inc. (RMD): Price and Financial Metrics


ResMed Inc. (RMD): $279.48

-3.27 (-1.16%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RMD POWR Grades


  • RMD scores best on the Stability dimension, with a Stability rank ahead of 92.31% of US stocks.
  • The strongest trend for RMD is in Sentiment, which has been heading down over the past 48 weeks.
  • RMD's current lowest rank is in the Value metric (where it is better than 43.94% of US stocks).

RMD Stock Summary

  • With a market capitalization of $41,191,355,342, Resmed Inc has a greater market value than 93.35% of US stocks.
  • RMD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 500.38 -- higher than 93.66% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for RMD is currently 55.91, higher than 91.79% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Resmed Inc, a group of peers worth examining would be EBAY, A, HOLX, TEL, and TTWO.
  • Visit RMD's SEC page to see the company's official filings. To visit the company's web site, go to www.resmed.com.

RMD Valuation Summary

  • RMD's price/sales ratio is 13.2; this is 16.3% higher than that of the median Healthcare stock.
  • RMD's EV/EBIT ratio has moved down 23.1 over the prior 243 months.
  • RMD's price/earnings ratio has moved down 88.4 over the prior 243 months.

Below are key valuation metrics over time for RMD.

Stock Date P/S P/B P/E EV/EBIT
RMD 2021-08-31 13.2 14.7 89.2 47.2
RMD 2021-08-30 13.2 14.6 88.7 46.9
RMD 2021-08-27 13.1 14.5 88.1 46.6
RMD 2021-08-26 13.0 14.4 87.5 46.3
RMD 2021-08-25 13.0 14.4 87.7 46.4
RMD 2021-08-24 12.9 14.2 86.7 45.8

RMD Growth Metrics

  • Its 2 year revenue growth rate is now at 27.2%.
  • Its year over year net income to common stockholders growth rate is now at -10.81%.
  • The 3 year revenue growth rate now stands at 42.42%.
RMD's revenue has moved up $792,009,000 over the prior 33 months.

The table below shows RMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 3,196.825 736.718 474.505
2021-03-31 3,091.066 840.458 457.24
2020-12-31 3,091.754 883.875 698.858
2020-09-30 3,027.9 783.891 679.898
2020-06-30 2,957.013 802.255 621.674
2020-03-31 2,891.632 613.808 512.64

RMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RMD has a Quality Grade of B, ranking ahead of 82.26% of graded US stocks.
  • RMD's asset turnover comes in at 0.691 -- ranking 53rd of 183 Medical Equipment stocks.
  • PEYE, ASXC, and RSLS are the stocks whose asset turnover ratios are most correlated with RMD.

The table below shows RMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.691 0.575 0.410
2021-03-31 0.673 0.582 0.379
2020-12-31 0.676 0.582 0.342
2020-09-30 0.670 0.583 0.321
2020-06-30 0.672 0.581 0.300
2020-03-31 0.675 0.588 0.260

RMD Price Target

For more insight on analysts targets of RMD, see our RMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $261.67 Average Broker Recommendation 1.9 (Hold)

RMD Stock Price Chart Interactive Chart >

Price chart for RMD

RMD Price/Volume Stats

Current price $279.48 52-week high $301.34
Prev. close $282.75 52-week low $165.92
Day low $277.54 Volume 557,100
Day high $280.48 Avg. volume 592,464
50-day MA $278.86 Dividend yield 0.6%
200-day MA $226.44 Market Cap 40.71B

ResMed Inc. (RMD) Company Bio


ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.


RMD Latest News Stream


Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream


Loading social stream, please wait...

View Full RMD Social Stream

Latest RMD News From Around the Web

Below are the latest news stories about Resmed Inc that investors may wish to consider to help them evaluate RMD as an investment opportunity.

ResMed Inc. Consensus Indicates Potential -7.5% Downside

ResMed Inc. with ticker code (RMD) now have 6 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The range between the high target price and low target price is between 312 and 230 calculating the average target price we see 261.67. Given that the stocks previous close was at 282.75 this would indicate that there is a downside of -7.5%. The day 50 moving average is 285.74 and the 200 moving average now moves to 234.59. The market cap for the company is $40,715m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="RMD" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healt...

DirectorsTalk | September 25, 2021

Gut health medtech Atmo Biosciences raises $9.6m, IPO next year

Atmo Biosciences, led by a former ResMed engineer, is catching investors attention ahead of its IPO next year.

The Australian Financial Review | September 23, 2021

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | September 23, 2021

Investors in ResMed (NYSE:RMD) have made a massive return of 377% over the past five years

Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...

Yahoo | September 22, 2021

Respiratory and Anesthesia Disposables Market 2021 Clinical Research with Top Leading Companies | Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Becton, Dickinson and Company (BD), Teleflex Incorporated, ResMed, Smiths Group plc.

The Respiratory and Anesthesia Disposables Market is present scenario evidently states that the pandemic will continue to determine various aspects of the healthcare industry in foreseeable future, as a result, the demand for disposables such as masks, filters, nasal cannulas,

OpenPR | September 11, 2021

Read More 'RMD' Stories Here

RMD Price Returns

1-mo -2.59%
3-mo 13.65%
6-mo 44.55%
1-year 66.53%
3-year 149.75%
5-year 360.84%
YTD 32.20%
2020 38.33%
2019 37.85%
2018 36.38%
2017 39.06%
2016 18.01%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8597 seconds.